VANIQA

This brand name is authorized in United States. It is also authorized in Austria, Canada, Croatia, Estonia, Finland, France, Ireland, Israel, Italy, Lithuania, Netherlands, Poland, Romania, Spain, UK.

Active ingredients

The drug VANIQA contains one active pharmaceutical ingredient (API):

1
UNII 4NH22NDW9H - EFLORNITHINE HYDROCHLORIDE
 

Eflornithine irreversibly inhibits ornithine decarboxylase, an enzyme involved in the production of the hair shaft by the hair follicle. Eflornithine has been shown to reduce the rate of hair growth.

 
Read more about Eflornithine

Medication package inserts

Below package inserts are available for further reading:

Document Type Information Source  
 VANIQA Cream MPI, EU: SmPC European Medicines Agency (EU)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group Classification
D11AX Other dermatologicals D Dermatologicals → D11 Other dermatological preparations → D11A Other dermatological preparations
Discover more medicines within D11AX
D11AX16 Eflornithine D Dermatologicals → D11 Other dermatological preparations → D11A Other dermatological preparations → D11AX Other dermatologicals
Discover more medicines within D11AX16

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
CA Health Products and Food Branch 02243837
EE Ravimiamet 1204805, 1204816, 1204827, 1849732
ES Centro de información online de medicamentos de la AEMPS 01173002
FI Lääkealan turvallisuus- ja kehittämiskeskus 384794
FR Base de données publique des médicaments 64328981
GB Medicines & Healthcare Products Regulatory Agency 149460
IE Health Products Regulatory Authority 52311, 52348
IL מִשְׂרַד הַבְּרִיאוּת 7293
IT Agenzia del Farmaco 035115017, 035115029, 035115031
LT Valstybinė vaistų kontrolės tarnyba 1031136, 1031137, 1031138
NL Z-Index G-Standaard 16164784
NL Z-Index G-Standaard, PRK 127264
PL Rejestru Produktów Leczniczych 100210697
RO Agenția Națională a Medicamentului și a Dispozitivelor Medicale W53290001, W53290002, W53290003
US FDA, National Drug Code 0023-4857

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.